Endovita - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 243,264 | 213,267 | 225,049 | 323,524 | 460,265 | 728,387 | 616,487 | 1,764 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 20,178 | 16,119 | 5,677 | 6,240 | 9,399 | 602 | -13,677 | -24,832 |
| Equity | 51,197 | 43,672 | 49,030 | 20,544 | 30,017 | 29,929 | 15,803 | -9,029 |
| Liabilities | 7,741 | 5,837 | 12,858 | 20,616 | 75,905 | 94,371 | 43,518 | 37,825 |
| Non-current assets | 18,655 | 7,410 | 5,514 | 5,059 | 67,226 | 53,461 | 38,372 | 27,557 |
| Current assets | 40,283 | 42,099 | 56,374 | 36,101 | 38,696 | 70,839 | 20,949 | 1,239 |
| Total assets | 58,938 | 49,509 | 61,888 | 41,160 | 105,922 | 124,300 | 59,321 | 28,796 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 121,088 | 103,077 | 882 |
| Social insurance contributions | - | - | - | - | - | 74,975 | 73,245 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +2.5% | -12.3% | +5.5% | +43.8% | +42.3% | +58.3% | -15.4% | -99.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 34.2% | 32.6% | 9.2% | 15.2% | 8.9% | 0.5% | -23.1% | -86.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 39.4% | 36.9% | 11.6% | 30.4% | 31.3% | 2.0% | -86.5% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.3% | 7.6% | 2.5% | 1.9% | 2.0% | 0.1% | -2.2% | -1407.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 0.3 | 1.0 | 2.5 | 3.2 | 2.8 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 19,461 | 17,896 | 25,477 | 37,692 | 44,542 | 67,236 | 63,229 | 882 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Endovita - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-22 | 7.28 |
Endovita - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-01 | 2025-05-08 | 7.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Endovita, UAB (code 303350457) is a Private Limited Liability Company engaged in dental practice care activities. In 2025, the company generated €1.8K in revenue and recorded a net loss of €24.8K, with profitability deteriorating sharply after the low-margin result of 2023 and the loss recorded in 2024. Revenue moved from €728.4K in 2023 to €616.5K in 2024, then fell to a very small level in 2025, showing a pronounced downward trajectory over the latest three years. At the same time, equity weakened from €29.9K in 2023 to €15.8K in 2024 and turned negative at -€9.0K in 2025. Total assets declined from €124.3K to €59.3K and then to €28.8K, while liabilities decreased from €94.4K in 2023 to €43.5K in 2024 and €37.8K in 2025. Long-term assets remained the main component of the balance sheet in 2025, at €27.6K. Revenue per employee was €882 in 2025, reflecting very limited operating activity and weak productivity in the latest year.